Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer.
about
Treatment of ovarian cancer beyond chemotherapy: are we hitting the target?Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast CancerLeveraging PET to image folate receptor α therapy of an antibody-drug conjugate
P2860
Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Profile of vintafolide (EC145) ...... inum-resistant ovarian cancer.
@en
Profile of vintafolide
@nl
type
label
Profile of vintafolide (EC145) ...... inum-resistant ovarian cancer.
@en
Profile of vintafolide
@nl
prefLabel
Profile of vintafolide (EC145) ...... inum-resistant ovarian cancer.
@en
Profile of vintafolide
@nl
P2860
P356
P1476
Profile of vintafolide (EC145) ...... inum-resistant ovarian cancer.
@en
P2093
Jean-François Baurain
Raffaella Votino
P2860
P304
P356
10.2147/IJWH.S39696
P407
P577
2014-03-31T00:00:00Z